tiprankstipranks
ANI Pharmaceuticals sees FY24 adjusted EPS, revenue ‘at or above’ guidance
The Fly

ANI Pharmaceuticals sees FY24 adjusted EPS, revenue ‘at or above’ guidance

ANI previously forecast FY24 adjusted EPS $4.90-$5.05, consensus $5.02, and FY24 revenue $594M-$602M, consensus $598.67M.

Stay Ahead of the Market:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles